Temporal analysis of clinico-pathological variables and biomarkers in cancer

Read full text Summarise with VIRAT
Authors: Sophia R. Halliday
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Blood biomarkers are commonly used in many cancers to help diagnose disease or predict survival. However, these biomarkers are often dichotomised to facilitate easy analysis and interpretation. This categorisation removes a vast amount of information, particularly either side of the enforced boundaries, which otherwise could give improved insights into the prognosis of individuals. This research focuses on using blood biomarkers measured at diagnosis, pre-treatment and post-treatment, in continuous form, to develop prognostic models in prostate (PCa) and oesophageal (OAC) cancers.

Fields of Study & Subjects

Inflammatory Biomarkers in Disease Prognosis Breast Cancer Treatment Studies Statistical Methods in Epidemiology

Publication details

Journal / source
Research Portal (Queen's University Belfast)
Publication date
1 October 2026
Language
EN
Document type
Thesis